Discipline Based Literature Review
Practitioner Review: Anxiety disorders in children and young people – assessment and treatment
Cathy Creswell,1,2 Polly Waite,1,2,3 and Jennie Hudson4 1Department of Experimental Psychology, University of Oxford, Oxford, UK; 2Department of Psychiatry, University of Oxford, Oxford, UK; 3School of Psychology and Clinical Language Sciences, University of Reading, Reading, UK;
4Centre for Emotional Health Macquarie University, Sydney, NSW, Australia
Despite significant advancements in our knowledge of anxiety disorders in children and adolescents, they continue to be underrecognised and undertreated. It is critical that these disorders are taken seriously in children and young people as they are highly prevalent, have a negative impact on educational, social and health functioning, create a risk of ongoing anxiety and other mental health disorders across the life span and are associated with substantial economic burden. Yet very few children with anxiety disorders access evidence-based treatments, and there is an urgent need for widespread implementation of effective interventions. This review aimed to provide an overview of recent research developments that will be relevant to clinicians and policymakers, particularly focusing on the development and maintenance of child anxiety disorders and considerations for assessment and treatment. Given the critical need to increase access to effective support, we hope this review will contribute to driving forward a step change in treatment delivery for children and young people with anxiety disorders and their families. Keywords: Anxiety disorders; children; adolescents; intervention; treatment; assessment.
Introduction Anxiety disorders are the most prevalent mental health disorders in children and young people (see Table 1 for DSM classification and prevalence esti- mates). In their worldwide review of the prevalence of mental disorders in children and young people, Polanczyk, Salum, Sugaya, Caye and Rohde (2015) reported a mean prevalence of 6.5% based on studies conducted between 1985 and 2012; however, this is highly likely to be an underestimate of the current situation given recent findings from consecutive national surveys in England in which there was a 51% increase in the reported prevalence of anxiety disorders between 2004 and 2017 (Vizard, Pearce, & Davis, 2018). Given the significant negative impact of childhood anxiety disorders on educational, social and health functioning, the risk of ongoing anxiety and other mental health disorders in adulthood (Copeland, Angold, Shanahan, & Costello, 2014) and the substantial economic burden (Fineberg et al., 2013), this recent increase in reported preva- lence is extremely concerning and reflects an urgent need for effective, early intervention.
Aims of this review The last three decades have seen a burgeoning of research into the treatment of anxiety disorders in children and adolescents, with a number of meta- analyses published over the last decade. Here, we have focused on recent developments in the field
that will be of most relevant to clinical practitioners, specifically, recent literature on the development and maintenance of anxiety disorders, assessment and intervention. In line with the bulk of the literature in this field, we have focused primarily on school-aged children and young people (4– 18 years).
Development of anxiety disorders in children and young people The two most robust predictors of the development of anxiety disorders in children are inhibited tempera- ment (the tendency to withdraw, avoid or respond fearfully to new situations), which increases the risk of later anxiety disorders more than sevenfold (Clauss & Blackford, 2012) and having a parent with an anxiety disorder, which raises the risk almost twofold (Lawrence, Murayama, & Creswell, 2019). These findings are in keeping with evidence from twin, family and adoption studies that suggest heritability rates of between 25% and 50% for child anxiety symptoms (Cheesman, Rayner, & Eley, 2019), but also highlight the substantial role of the environment. Because of the inter-familial risks of anxiety disorders, research on environmental risk factors has predominantly focused on parenting behaviours, where there is some longitudinal and experimental research evidence for a causal role of parental overinvolvement/control (de Wilde & Rapee, 2008; Hudson & Dodd, 2012; Rubin, Burgess, & Hastings, 2002; Thirlwall & Creswell, 2010). How- ever, a growing body of work highlights the reciprocal relationship between child inhibition/anxiety and parental involvement/control, in which parental
Conflict of interest statement: See Acknowledgements for full
disclosures.
© 2020 Association for Child and Adolescent Mental Health Published by John Wiley & Sons Ltd, 9600 Garsington Road, Oxford OX4 2DQ, UK and 350 Main St, Malden, MA 02148, USA
Journal of Child Psychology and Psychiatry 61:6 (2020), pp 628–643 doi:10.1111/jcpp.13186
PFI_12mmX178mm.pdf + eps format
involvement/control is both elicited by child inhibi- tion/anxiety and influences it’s development (Eley, Napolitano, Lau, & Gregory, 2010; Hudson, Doyle, & Gar, 2009). Experimental and longitudinal evidence also supports a causal role of parental modelling and transference of fear information (e.g. Field & Lawson, 2003), although to date these studies have focused on the development of fear or avoidance, rather than anxiety disorders per se. Despite quite extensive research attention, evidence for a role of parental negativity in the development of child anxiety disorders is generally lacking (Lawrence, Waite, & Creswell, 2019).
Notably, where particular parental behaviours appear to have an effect on child anxiety disorders, this is likely to vary according to child characteris- tics, including the child or young person’s age or stage of development (e.g. Waite & Creswell, 2015), and the young person’s temperament. For example, children with higher levels of behavioural inhibition or trait anxiety have been found to respond to maternal expressed anxiety or control with a more fearful response, compared to those with lower levels (De Rosnay, Cooper, Tsigaras, & Murray, 2006; Thirlwall & Creswell, 2010). Furthermore, in a recent longitudinal study behaviourally inhibited preschoolers only had higher anxiety symptoms at 12 years of age when there had been high maternal overinvolvement at age 4 years, and effects were mitigated when mothers demonstrated low overin- volvement (Hudson, Murayama, Meteyard, Morris, & Dodd, 2019).
In terms of broader environmental factors, the role of life events and peer relationships has also been examined, though to a lesser extent, bringing further evidence of reciprocal relationships between ‘risk’ factors and childhood anxiety disorders (Broe- ren, Newall, Dodd, Locker, & Hudson, 2014; Kim, Conger, Elder, & Lorenz, 2003). Here too, it is likely that these relationships are influenced by age, temperament and other moderating factors (Broeren et al., 2014; Turner, Beidel, & Wolff, 1996). Research in other areas of the environment, such as economic adversity, sibling relationships, social media and school environment, has received limited attention to date, but it is likely that in some instances they may create risks for the development and maintenance of anxiety (Keles, McCrae, & Grealish, 2019), as well as potential opportunities for support and intervention (Keeton, Teetsel, Dull, & Ginsburg, 2015).
Maintenance of anxiety disorders in children and young people In contrast to models of anxiety disorders in adults which have tended to focus on maintenance factors (i.e. factors that prevent new learning in feared situations; e.g. Clark, 1986; Clark & Wells, 1995; Rapee & Heimberg, 1997), models of anxiety
disorders in children and adolescents (e.g. Spence & Rapee, 2016) have tended to focus more on developmental risk factors – meaning we have quite
Table 1 Characteristics and prevalence of DSM-5 anxiety disorders in children and adolescents
Anxiety disorder Clinical characteristics
Recent example prevalence figures (%)a
Separation anxiety disorder
Excessive fear of separation from primary caregiver(s)
0.7
Specific phobia
Marked fear or anxiety about a specific object or situation (e.g. an animal, injections, vomit) that almost always provokes immediate fear or anxiety
0.8
Social anxiety disorder
Marked fear or anxiety about social situations in which the young person is exposed to possibly scrutiny by others, and fears they will act in a way or show anxiety symptoms that will be negatively evaluated
0.8
Generalised anxiety disorder
Excessive and uncontrollable worry about a number of events or activities, associated with at least 3 symptoms (e.g. muscle tension, difficulty concentrating, sleep disturbance)
1.5
Panic disorder
Recurrent, unexpected panic attacks that which are not restricted to a particular situation and concern about future attacks and/or a change in behaviour related to the attacks
1.1
Agoraphobia Marked fear or anxiety about 2 or more of the following situations: using public transport, being in open spaces, being in enclosed spaces, being in a crowd or standing in a line, or being outside of the home alone
0.5
Selective mutism
Consistent failure to speak in specific social situations (e.g. school) where there is an expectation to speak, despite speaking in other situations
0.18%–1.90%b
Prevalence data are from Vizard et al. (2018) for all anxiety disorders except selective mutism. We have not combined with other recent prevalence studies as data are not comparable due to different time periods covered (e.g. Spence, Zubrick, & Lawrence, 2018). aFigures represent point prevalence (proportion who meet criteria for a diagnosis at a specific point in time). bFigures taken from Muris and Ollendick’s (2015) review; the variation in prevalence rates identified is likely to be due to variability in the strictness of the diagnostic criteria employed.
© 2020 Association for Child and Adolescent Mental Health
doi:10.1111/jcpp.13186 Anxiety disorders in children and young people 629
limited understanding on which to base the content of treatments (Halldorsson & Creswell, 2017). How- ever, there is emerging evidence that similar cogni- tive processes may occur in children and young people to those described in adult cognitive models, for example, associations between self-focused attention and social anxiety (Hodson, McManus, Clark, & Doll, 2008) and intolerance of uncertainty and worry (Fialko, Bolton, & Perrin, 2012) in young people. To date, these studies have largely been carried out using cross-sectional designs in nonclin- ical populations in varying, and often wide, age groups. Going forward, experimental studies to test causal and maintaining processes in children and young people are needed, that can take account of children and young people’s cognitive maturity and social context, in order to develop specific develop- mentally tailored interventions (e.g. Leigh & Clark, 2018).
Assessment There is a high degree of comorbidity among anxiety disorders in children and young people, particularly with other anxiety disorders across the age range (Leyfer, Gallo, Cooper-Vince, & Pincus, 2013), and mood disorders in adolescence (Essau, 2003). How- ever, separate anxiety disorders can be adequately and reliably diagnosed (Spence, 2017). To assess DSM-5 anxiety disorders, a multimethod and multi- informant approach is recommended (Hudson, New- all, Schneider, & Morris, 2014; Kazdin, 2003; Silverman & Ollendick, 2005) using (a) interview schedules, (b) questionnaire measures and where applicable, (c) observational approaches.
Interview schedules
Of these three methods, structured diagnostic inter- views such as the Anxiety Disorders Interview Schedule for children and parents (Silverman & Albano, 1996) are considered to be the ‘gold stan- dard’. While they are commonly used in research trials, standardised assessments, such as the ADIS- C/P, are rarely used systematically in clinical set- tings, bringing risks that specific anxiety disorders may be missed or misdiagnosed, and that children and young people may not respond to the nonspeci- fic interventions that they often receive (Craddock et al., 2008). These risks have led to recommenda- tions that standardised assessments should be used as an adjunct to clinical assessment (Martin, Fish- man, Baxter, & Ford, 2011).
Structured diagnostic interviews provide a com- prehensive assessment of anxiety (including symp- toms, severity and interference) using independent information from both the parent or carer and the child or adolescent. Given the high degree of comor- bidity among disorders, a comprehensive assess- ment considers all anxiety and related disorders (e.g.
mood and behaviour disorders) in order to obtain accurate differential diagnoses at the start of treat- ment, and also to determine the success of the treatment approach in reducing the presence and severity of, not only the most interfering (i.e. primary) diagnosis, but also all anxiety diagnoses. As anxiety disorders are associated with increased risk of suicidal ideation (O’Neil Rodriguez & Kendall, 2014) and other factors that increase the risk of suicidal ideation and behaviour (e.g. being bullied by peers, alcohol and drug problems, and poor academic and vocational achievement; (Reijntjes, Kamphuis, Prin- zie, & Telch, 2010; Robinson, Sareen, Cox, & Bolton, 2011), a comprehensive interview assessment should also include an appropriate assessment of risk of suicide and self-injury.
One of the significant methodological issues that arises when using an interview schedule is that clinicians need to manage differing perspectives provided by parents and children regarding anxiety symptom presence, severity and impairment (Choudhury, Pimentel, & Kendall, 2003; Grills & Ollendick, 2003) in order to make appropriate clin- ical decisions. Although clinicians are more likely to be influenced by the parent than the child’s per- spective (Grills & Ollendick, 2003), particularly among preadolescents, it is often difficult to deter- mine which report is more valid. To ensure equiva- lent value is placed on both the child or adolescent’s report and that of the parent, clinicians are encour- aged to use the ‘OR rule’ (Comer & Kendall, 2004) in which the diagnostic profile includes clinically inter- fering symptoms when they are reported by either the young person or the parent, unless doing so would lead to double counting of the same symp- toms.
Questionnaire measures
Diagnostic interviews are typically supplemented with psychometrically reliable and valid question- naire measures from multiple sources (e.g. parent, young person, teacher) to assess anxiety symptoms and/or impairment. Although questionnaire mea- sures should be used in conjunction with interviews, they bring advantages of ease of administration and resulting reductions in time and cost. Further, combining questionnaire data from parents and the young person leads to a richer and sometimes more accurate perspective of the child’s symptoms (Rear- don, Creswell, et al., 2019). Most youth-reported questionnaires are designed for children 7 years and up; however, children’s reading and cognitive ability at this age vary dramatically and research has highlighted that a portion of children do not under- stand the questionnaires presented to them (White & Hudson, 2016). It is therefore important to consider whether the measure is appropriate for the child’s developmental stage when deciding which reporters to include and which questionnaire measures to
© 2020 Association for Child and Adolescent Mental Health
630 Cathy Creswell et al. J Child Psychol Psychiatr 2020; 61(6): 628–43
choose. Teacher report can also help add to clini- cian’s understanding of the child’s presenting prob- lems, particularly for school-specific or classroom- specific symptoms; however, this may not always be practical to obtain (e.g. as children move classes/ schools) and there is limited evidence of reliability and validity (although see Lyneham, Street, Abbott & Rapee, 2008; Reardon, Spence, Hesse, Shakir, & Creswell, 2018 for initial promising findings).
A host of measures has been developed to assess multidimensional anxiety symptoms in children and adolescents that are available in both parent report and youth report, such as the Spence Children’s Anxiety Scale [SCAS: (Nauta et al., 2004; Spence, Barrett, & Turner, 2003), Screen for Child Anxiety and Related Emotional Disorders (SCARED); (Birmaher et al., 2003) and the Multidimensional Anxiety Scale for Children (MASC; March, Parker, Sullivan, Stal- lings, & et al., 1997). These measures have typically been informed by earlier editions of the Diagnostic and Statistical Manual of Mental Disorders (e.g. DSM- IV; American Psychiatric Association, 1994), with the exception of the Youth Anxiety Measure – 5 (Muris et al., 2017)] which adds selective mutism items bringing it in line with DSM-5 (American Psychiatric Association, 2013) and ICD-11 (Reed et al., 2019). To detect elevated symptoms, the measure needs to have available established normative data – ideally cultur- ally relevant – to indicate the degree to which the symptoms compare to other children of the same age and gender and the extent to which they can accu- rately identify children and adolescents with/out anxiety disorders. Multidimensional measures pro- vide an overall score for anxiety as well as a subscale score for symptoms of specific anxiety disorders. Recent data from a large collaborative study of 10 international child anxiety clinics suggest that the SCAS can be useful in differentiating some (e.g. social anxiety disorder and separation anxiety disorder) but not all of the anxiety disorders (e.g. generalised anxiety disorders and specific phobias) in children (Reardon, Creswell, et al., 2019).
Depending on the child’s specific presentation and the focus of treatment, clinicians may also choose to include additional disorder-specific measures. For example, if social anxiety disorder is the focus of treatment, there are a number of measures specifi- cally designed to assess social anxiety symptoms (e.g. Social Phobia and Anxiety Inventory – Children; Beidel, 1996). Given the common co-occurrence of depression, particularly in adolescence, and its likely impact on treatment outcomes (Hudson et al., 2015), it is also important to include measures of depressive symptoms such as the Short Mood and Feelings Questionnaire (SMFQ; Angold, 1995) or using a combined measure such as the Revised Child Anxiety and Depression Scale (RCADS; Chor- pita, Yim, Moffitt, Umemoto, & Francis, 2000).
The assessment of anxiety symptoms in children with autism spectrum disorders (ASD) has received
increasing attention over the last few years with evidence questioning the appropriateness of existing anxiety measures (Glod et al., 2017). Specifically, parents of ASD children respond differently to par- ticular items of the SCAS-P compared with parents of typically developing children (Toscano et al., under review) and the factor structure differs (e.g. Jitlina et al., 2017; Magiati et al., 2017). These results highlight that questionnaire measures designed and evaluated with typically developing children should be used with caution in children with ASD and, although there may some utility in determining a total anxiety score, clinicians should not rely on the subscales from multidimensional measures such as the SCAS-P, particularly those that measure phys- ical injury fears and obsessive–compulsive disorder symptoms, when working with children with ASD (Magiati et al., 2017; Toscano et al., under review).
In addition to symptom severity, a number of questionnaires have been developed to assess gen- eral functioning and impairment, such as the Barkley Functional Impairment Scale for Children and Adolescents (Barkley, 2012), or the Child and Adolescent Social and Adaptive Functioning Scale (Price, Spence, Sheffield, & Donovan, 2002). We have found the Child Anxiety Life Interference Scale (Lyneham et al., 2013) and the Child Anxiety Impact Scale (Langley, Bergman, McCracken, & Piacentini, 2004) particularly useful as they were developed to assess the specific impact of anxiety symptoms on the child’s life at home, outside the home as well as the impact on the parent’s life. Recent evidence indicates that parent-reported life interference is a good indicator of child anxiety diagnostic status (Evans, Thirlwall, Cooper, & Creswell, 2017).
Observational assessment
Observational assessments are infrequently used outside of research settings but can be used to determine the level of fear or anxiety experienced when the child is exposed to threatening stimuli. For example, behavioural approach tasks (BAT) involve the child taking steps of increasing difficulty towards a feared object or situation in a controlled environ- ment. BATs can provide critical information about fear levels (Ollendick, Lewis, Cowart, & Davis, 2012) and can be particularly informative in situations where there has been inconsistent or unreliable reporting on diagnostic and questionnaire measures.
Treatment: psychological interventions The most frequently evaluated psychological treat- ment for anxiety disorders in children and young people is cognitive behaviour therapy (CBT), which typically involves the application of exposure to enable children and young people to confront feared situations, typically in a graded fashion, in order to develop new learning about what really happens when
© 2020 Association for Child and Adolescent Mental Health
doi:10.1111/jcpp.13186 Anxiety disorders in children and young people 631
they enter anxiety-provoking situations. In CBT pro- grammes, exposure is typically accompanied by cog- nitive restructuring procedures, to help children identify and challenge negative automatic thoughts. Some programmes also include other forms of skills training, such as relaxation, social skills and prob- lem-solving training. It has consistently been con- cluded, across a number of meta-analyses, that CBT shows clear benefits over waitlist controls, with, for example, an overall response rate of 59.4% for CBT versus 17.5% for controls (e.g. James et al., 2013). While there are some positive indications of sustained benefits of CBT over the long-term (e.g. Gibby, Cas- line, & Ginsburg, 2017), others have found high relapse rates (Ginsburg et al., 2018). Overall, very few studies have been able to maintain a control condition over the long-term (e.g. James et al, 2013) limiting conclusions that can be made.
Does the format of delivery matter?
A recent systematic review of psychotherapies for childhood anxiety disorders (Zhou et al., 2019) iden- tified 101 randomised controlled trials (RCTs) includ- ing 11 categories of psychotherapy, which all involved CBT (or behavioural therapy) but in a range of formats (individual, group, bibliotherapy, Internet assisted – with/out parent involvement or child/ parent only). On the basis of a network meta-analysis (which compares more than two interventions to each other in a single meta-analysis), there was some evidence that groups may be a particularly effective format. However, these findings need to be inter- preted with caution, given that group treatments have not been found to be more effective than individual treatments when compared directly (e.g. Manassis et al., 2002) and trials which have taken a group approach may disproportionately reflect other important study characteristics, including particular aged participants and intervention settings (e.g. clinic versus community). Going forward, we need sufficiently powered RCTs that allow us to make head-to-head comparisons between different treat- ment formats. The inclusion of health economic analyses to address these questions will be critical, as it is far from clear that group-based treatments are necessarily more cost-effective than individual approaches, as illustrated in the case of social anxiety disorder in adults (NICE, 2013). On the other hand, other treatment formats have promising evi- dence and may bring particular economic advantages [e.g. bibliotherapy (Yuan et al., 2018)], computerised and Internet-based interventions (e.g. Ebert et al., 2015; and see below section: ‘Improving access to psychological treatments’). Youth and parent prefer- ences should also be considered; for example, there is promising evidence for treatment of specific phobias delivered predominantly within a single (extended) treatment session (e.g. Ollendick et al., 2009) and this intensive approach has been found to be highly
motivating and acceptable in adult settings (e.g. Bevan, Oldfield, & Salkovskis, 2010).
What are the important treatment components?
There has been very little examination of how what is actually done within the CBT programme relates to treatment outcome. This is a serious shortcoming, given recent evidence that certain procedures can either enhance or inhibit new, adaptive learning (e.g. Craske, Treanor, Conway, Zbozinek, & Vervliet, 2014). However, the few notable exceptions include an examination of the trajectory of symptom change in the large U.S. CAM trial (n = 488; 7–17 years) in which the introduction of both cognitive restructuring (which involved changing self-talk) and exposure tasks significantly accelerated the rate of progress on measures of symptom severity and global func- tioning moving forward in treatment, whereas the introduction of relaxation training had limited impact (Peris et al., 2015). Notably, improvements in coping efficacy were a significant mediator of treatment gains, but improvements in anxious self-talk were not (Kendall et al., 2016). These findings suggest that treatments might be more efficiently delivered by promoting new learning (particularly about coping) through exposure. This conclusion was also sup- ported by a recent meta-analysis that concluded that introducing anxiety management strategies before exposure does not increase the efficacy of treatment (Ale, McCarthy, Rothschild, & Whiteside, 2015). Recent dismantling studies also provide consistent preliminary findings; for example, exposure therapy (in which parents are trained how to facilitate expo- sure outside sessions) achieved greater improve- ments than an intervention that only involved the anxiety management strategies that are typically administered preexposure, such as identifying feel- ings and anxious cognitions, relaxation and problem- solving (Whiteside et al., 2015). Notably, different treatment formats may promote different pathways to recovery as indicated by Silverman et al.’s recent (2019) findings that reductions in parental psycho- logical control mediated outcomes from ‘parent involvement CBT’ whereas positive peer-youth rela- tionships mediated outcomes from group CBT with peers. Together, these findings indicate that the opportunity to learn through exposure is key and that this may be optimised in a number of different ways.
What should we deliver to whom?
The majority of trials of CBT for child anxiety disorders have evaluated outcomes for mixed anxiety disorders (74% in Zhou et al., 2019), typically including children presenting with social anxiety disorder, generalised anxiety disorder, separation anxiety disorder, obsessive–compulsive disorder and specific phobias. However, a number of recent stud- ies have identified that children with social anxiety
© 2020 Association for Child and Adolescent Mental Health
632 Cathy Creswell et al. J Child Psychol Psychiatr 2020; 61(6): 628–43
disorder benefit less from generic CBT approaches than children with nonsocial forms of anxiety disor- ders (e.g. posttreatment remission rates of 40.6% vs. 72.0%, Ginsburg et al., 2011; 22.3% vs. 42.1%– 52.7%, Hudson et al., 2015). The reasons for this remain unclear, with hypotheses including a lack of focus on relevant exposures (e.g. Ginsburg et al., 2011), potential disorder-specific maintenance fac- tors that may not be addressed in current treatments (e.g. Halldorsson & Creswell, 2017) and/or social skills deficits (e.g. Beidel, Turner, & Morris, 2000). To date, RCTs of social anxiety disorder-specific treatments have predominantly focused on address- ing potential social skills deficits with consistent findings that they are effective in comparison with waitlist control conditions or active, nonspecific control interventions (e.g. Beidel et al., 2000; Dono- van & March, 2014; €Ost, Cederlund, & Reuterski€old, 2015; Spence, Donovan, & Brechman-Toussaint, 2000), and in meta-analyses, these treatments have fared better than generic forms of CBT (e.g. Rey- nolds, Wilson, Austin, & Hooper, 2012). However, in a head-to-head comparison of social anxiety disor- der-specific treatment (including social skills train- ing and a focus on factors identified in cognitive models of social anxiety disorder) and traditional generic CBT (both delivered online to 125 8- to 17- year-olds), Spence (2017) found no significant dif- ference in outcomes between these two active treat- ments. In contrast, promising findings have come out of recent studies that have put a particular focus on putative cognitive maintenance mechanisms of social anxiety disorder, at least among adolescents (Ingul, Aune, & Nordahl, 2014; Leigh & Clark, 2015).
In addition to social anxiety disorder, other pre- dictors that have been identified (albeit inconsis- tently) include depression, externalising disorders and parental psychopathology (Hudson et al., 2015). These factors appear to work in a cumulative linear way: the more pretreatment risk factors, the poorer the child’s outcomes following treatment (Hudson et al., 2013). This suggests we need to improve treatment for those children we can identify, at pretreatment, who possess these risk factors. When it comes to comorbid conditions, there is some evidence, albeit preliminary, to suggest that modular treatments (i.e. treatments in which procedures from evidence-based treatments for commonly comorbid disorders are structured as free-standing modules, which can be used as appropriate depending on particular client characteristics, e.g. Weisz et al., 2012) may lead to enhanced outcomes. For example, in a study by Weisz et al. (2012) modular treatment showed enhanced outcomes on parent-reported internalising symptoms (but not on disorder remis- sion) compared with standard CBT. When it comes to parental anxiety, it remains unclear exactly how best to improve child outcomes (e.g. Hudson, Newall, Rapee, et al., 2014), although recent studies indicate that good outcomes can be achieved when parents
are supported as part of, or alongside, their child’s treatment (Creswell et al., 2020; Hiller et al., 2016).
Does parental involvement improve treatment?
A final way in which CBT protocols have differed across trials is in how parents have been involved in treatment. Parental involvement ranges from briefly joining sessions to provide and hear updates, to being the primary recipient of the intervention. Where meta-analyses have considered the moderating role of parental involvement on treatment outcome, they have typically failed to find a significant benefit from including parents (Hiller et al., 2016; Thulin, Svirsky, Serlachius, Andersson, & Ost, 2014; Zhou et al., 2019). These findings are typically limited, however, by binary categorisations of whether or not parents are (substantially) involved in treatment rather than how parents are involved. It is understandable that parental involvement will not enhance treatment outcomes if parents are not being included in ways that, for example, are likely to enhance learning through exposure, and, equally, that parental involvement may have detrimental effects on out- comes if it is done in such a way that weakens the dose of critical ingredients of treatment (e.g. Taboas, McKay, Whiteside, & Storch, 2015). This emphasises the need for a more nuanced approach to parental involvement in CBT for child anxiety disorders going forwards and a recognition that this may differ in particular circumstances, on the basis of child, parent and broader environmental factors.
Are treatments applicable across populations/ settings?
To date, RCTs of CBT have predominantly be con- ducted in Western countries, with Caucasian, rela- tively affluent populations. It is clear that far more extensive investigation is needed to evaluate psy- chological treatments for child anxiety disorders among more diverse populations and settings, par- ticularly given the promising findings that suggest that children from ethnic minorities (specifically Hispanic/Latino youth in the USA) can obtain sim- ilar outcomes to those from the dominant ethnic group (here European Americans), despite lower family incomes (Pina, Silverman, Fuentes, Kurtines, & Weems, 2003). A recent relevant example used bidirectional cultural adaptation to develop the Japanese Anxiety Children/Adolescents CBT (JACA-CBT) programme (Ishikawa et al., 2019), providing initial support for the transportability of CBT to a non-Western culture.
What is the effectiveness of non-CBT psychological therapies?
Unfortunately, at this stage very little can be con- cluded about psychological therapies other than
© 2020 Association for Child and Adolescent Mental Health
doi:10.1111/jcpp.13186 Anxiety disorders in children and young people 633
cognitive and behavioural therapies, as few RCTs have directly addressed the effectiveness of other psychotherapeutic approaches. Recent exceptions include an RCT by Silk et al. (2018), which compared individual CBT with supportive child-centred ther- apy (CCT). While the majority of 9- to 14-year-old children responded well to both conditions (respon- ders: 71% CBT, 56% CCT), CBT was associated with higher rates of full recovery posttreatment (67% vs. 47%) and one year later (82% vs. 65%). Another recent study compared CBT with acceptance and commitment therapy (ACT; Hancock et al., 2018), finding that both treatments were more effective than a waitlist control, with similar effect sizes (and recovery rates of 31% for ACT, 40% for CBT, compared to 8% for the waitlist control). Bringing this together, at this stage we are in a strong position to conclude that CBT is effective for anxiety disorders in children and young people compared with wait lists and attention controls (e.g. Hudson, Rapee, et al., 2009). However, we do not currently have strong evidence to conclude that any other psycho- logical intervention is effective, yet also have only limited evidence that CBT is better than other psychological approaches that are used in practice.
Specific considerations for different age groups
RCTs have tended to include children from across broad age ranges between 7 and 18 years, and there has been limited attention to the specific treatment needs of children and young people of different ages. Within the Zhou et al. (2019) review, only 14/101 trials specifically focused on preadolescents (i.e. those younger than 11 years) and only 23 focused specifi- cally on adolescents (i.e. those aged 11 or older), with the rest spanning these age ranges. This is surprising given the differing clinical characteristics of children and adolescents, with preadolescents being signifi- cantly more likely to have separation anxiety disorder, and adolescents significantly more likely to have primary social anxiety disorder, a comorbid mood disorder, more severe anxiety and school attendance difficulties (Waite & Creswell, 2014).
Preadolescents. Where psychological interventions have been looked at for younger children in their own right they have, overall, provided evidence for effec- tiveness (e.g. Zhang et al., 2017), however, there has been wide variability in the approaches taken, with some focusing specifically on the more common anxiety disorders in early childhood (e.g. separation anxiety disorder (Schneider et al., 2011), selective mutism (e.g. Oerbeck, Stein, Wentzel-Larsen, Langs- rud, & Kristensen, 2014), while others have included children with a broad range of anxiety disorders. A key difference in the delivery of interventions for younger children tends to include a greater focus on parental involvement, with evidence supporting the effective- ness for treatments delivered entirely via parents (e.g.
Cartwright-Hatton et al., 2011) and, in some cases, suggesting that similar outcomes can be achieved to those where children and parents are provided treat- ment in parallel (i.e. where twice as much therapy resource is provided; Waters, Ford, Wharton, & Cob- ham, 2009), suggesting that working via parents has the potential to provide a cost-effective approach to treatment for preadolescent children. However, given that some trials have showed less favourable out- comes for the parent-only approach (Monga, Rosen- bloom, Tanha, Owens, & Young, 2015), further research is needed to identify how to optimise both parental engagement and child outcomes through this promising treatment approach.
Adolescents. Where studies focus specifically on adolescents, the majority of RCTs have involved young people with primary social anxiety disorder (e.g. 62% of adolescent studies in Zhou et al., 2019) and those with large effect sizes have tended to include young people identified through screening in schools and include sessions within and outside schools to practice social skills (Masia Warner, Fisher, Shrout, Rathor, & Klein, 2007; Masia- Warner et al., 2005). Given these trials involve young people who are regularly attending school, it is unclear to what extent the findings will extend to those young people who experience high avoidance (and potentially symptom severity) which has led to difficulties attending school. Further research is clearly needed to identify how to optimise treatments for the full range of anxiety disorders experienced by adolescents, given the specific and challenging demands encountered during this transformational phase of life (Blakemore, 2018).
Psychological interventions for populations at particular risk
Elevated rates of anxiety disorders are often observed in particular populations such as children with physical health conditions (Pao & Bosk, 2011), intel- lectual disabilities (Maiano et al., 2018; Pao & Bosk, 2011), reading problems (Francis, Caruana, Hudson, & McArthur, 2019) and ASD (Kerns & Kendall, 2012). Treatment programmes have been developed for these specific populations; however, they have received limited evaluation to date with the exception of the treatment of anxiety disorders in the context of ASD.
Adaptations of CBT programmes to treat anxiety disorders in the context of ASD have typically aimed to ensure the delivery and content of treatment accounts for the sensitivities, unique symptoms and the visual and concrete learning styles com- monly observed in children with ASD, for example by increased use of visual aids, more structure, longer therapy length and an increased focus on relaxation and exposure homework (e.g. Chalfant, Rapee, & Carroll, 2007). While meta-analyses support the efficacy of CBT compared with waitlist controls
© 2020 Association for Child and Adolescent Mental Health
634 Cathy Creswell et al. J Child Psychol Psychiatr 2020; 61(6): 628–43
(James, James, Cowdrey, Soler, & Choke, 2013), it appears that treatment gains may be less likely to generalise to comorbid anxiety conditions with only 12.2% of children with ASD displaying full recovery at posttreatment (36.7% at follow-up; Warwick et al., 2017). Furthermore, the treatments that have been evaluated have typically been lengthy (with a recent study failing to find evidence of effectiveness of a low intensity, online treatment for children with ASD; Conaughton, Donovan, & March, 2017) and have, to date, neglected severely affected and/or nonverbal autistic children and young people.
How to improve psychological treatments?
In order to improve outcomes for children and ado- lescents with anxiety disorders, we need to develop and refine our ‘gold standard’ treatments, improve their translation into routine clinical settings and create sustainable environments within services that support their delivery. Exposure has been shown to be an important part of treatment (Ale et al., 2015; Peris et al., 2015; Whiteside et al., 2015); however, the extent to which (adult) contemporary models of expo- sure, and their application to optimise exposure (Craske et al., 2008), apply to children and adoles- cents remains unclear. Going forward, it will be important to understand what strategies promote new learning through exposure in young people at different stages of development, using treatment dismantling and experimental approaches, and to ensure that these are integrated into treatments (Waters & Craske, 2016). The use of technological advances, such as virtual reality, shown to be effective in delivering exposure in adults in a number of studies (e.g. Freeman et al., 2018), may also enable better and more meaningful in-session exposure; early signs are promising that virtual environments invoke anticipa- tory anxiety and are an acceptable medium for young people with social anxiety disorder (Parrish, Oxhan- dler, Duron, Swank, & Bordnick, 2016) and specific phobias in the context of ASD (Maskey, Lowry, Rodgers, McConachie, & Parr, 2014). Gamification may also increase young people’s engagement and willingness to undertake key elements of treatment (Fleming et al., 2017).
At the moment, our standard approaches to treat- ment rely on a ‘one-size-fits-all’ model. One of the potential ways in which we could improve outcomes is by personalising treatment to the individual needs and diagnostic profile of the young person and their family. Disorder-specific (e.g. Ingul, Aune, & Nordahl, 2014) and modular treatments may be one approach to achieve this (e.g. Weisz et al., 2012). However, to sufficiently refine this approach we need mainte- nance-focused, disorder-specific models (Hall- dorsson & Creswell, 2017) and to invest in large clinical trials and/or large data collaborations, to not only improve our understanding of predictors of psychological treatments, but also improve our
understanding of treatment mediators and modera- tors so that we can work towards more personalised approaches.
As we develop more targeted treatments, we also need to ensure that these are effectively implemented in routine practice. Successful implementation relies on a range of factors including clinicians’ knowledge about the effectiveness of interventions and their attitudes towards the intervention, as well as the provision of training and supervision to clinicians (Gunter & Whittal, 2010). Indeed, these factors appear to be particular barriers to the implementation of evidence-based treatments for child anxiety disorders. For example, Whiteside and colleagues found that, not only did clinicians in routine clinical settings water interventions down to make them shorter (Voort, Svecova, Jacobson, & Whiteside, 2010), they also rarely delivered exposure within treatment due to negative beliefs relating to safety, tolerability and ethics (Whiteside, Deacon, Benito, & Stewart, 2016). Furthermore, skills shortages in CBT have been doc- umented through national surveys of clinicians (Stal- lard, Udwin, Goddard, & Hibbert, 2007), although there are recent examples of programmes to increase the number of clinicians trained in evidence-based treatment, such as the Children and Young People’s Improving Access to Psychological Therapies (CYP- IAPT) programme in England (Fonagy, Pugh, & O’Her- lihy, 2017). It will be essential that ongoing efforts to train and supervise clinicians address not only knowl- edge and skills but also attitudes to ensure effective treatments are delivered in practice.
Improving access to psychological treatments
Even with the above adherence issues in mind, a very small proportion of children and adolescents who could benefit from interventions actually reach these interventions at all. In a recent study, only 2% of children with anxiety disorders identified in the com- munity in England had received CBT (Reardon, Har- vey, & Creswell, 2019). These findings are in keeping with previous studies indicating low rates of service utilisation more broadly in the United Kingdom, Australia and United States (Green et al., 2005; Lawrence et al., 2015; Merikangas et al., 2011). Barriers that parents frequently reported related to difficulties differentiating between developmentally appropriate and clinically significant anxiety, a lack of help-seeking knowledge, perceived negative conse- quences of help-seeking, and limited service provision (Reardon, Harvey, et al., 2019). These findings high- light the need for tools to help identify young people who may benefit from professional support to over- come difficulties with anxiety difficulties, as well as increased evidence-based provision for the treatment of anxiety disorders in children and young people.
One mechanism with potential to increase access to evidence-based interventions is a stepped care model in which the least costly intervention is
© 2020 Association for Child and Adolescent Mental Health
doi:10.1111/jcpp.13186 Anxiety disorders in children and young people 635
delivered initially, with more intensive (/expensive) interventions reserved for those who do not, or can be predicted not to, benefit from the first step treatment (Bower & Gilbody, 2005). A number of promising low-intensity approaches (i.e. brief and deliverable by nonspecialist therapists) have been developed and evaluated in recent years. For exam- ple, for preadolescents there is now good evidence that brief therapist-guided parent-led CBT (or par- ent-led bibliotherapy) is effective (e.g. Cobham, 2012; Rapee, Abbott, & Lyneham, 2006; Thirlwall et al., 2013), more cost-effective than an alternative brief intervention (Creswell et al., 2017), and similar outcomes can be achieved when delivered by non- specialist and specialist therapists (Thirlwall et al., 2013). In terms of low-intensity approaches for adolescents, there is promising evidence that online CBT may be a useful approach (Pennant et al., 2015; Spence et al., 2011) although positive benefits are less clear in routine practice (Waite, Marshall, & Creswell, 2019) and implementation remains a challenge for the field (e.g. Hill et al., 2018). Nonetheless, this appears to be an appealing mode of treatment delivery for at least some young people (e.g. Lenhard et al., 2016) that provides a valuable potential mechanism for delivering treatments at scale, enhancing treatment fidelity and analysing the effects of specific treatment components for young people with particular characteristics.
In the first systematic evaluation of a stepped care treatment approach for child anxiety disorders, Rapee et al. (2017) found that overall stepped care, comprising (a) low-intensity CBT (parent-led biblio- therapy for under 13-year-olds and computerised self-help for those 13 years or older), followed by (b) standard individual CBT, and then (c) individually tailored treatment, obtained similar outcomes to standard CBT, although stepped care required sig- nificantly less therapist time. While this time saving did not result in reduced health care costs, it did translate to lower costs from a societal perspective (including costs incurred by families; Chatterton et al., 2019). Notably, the authors highlight that the final step in the stepped care model failed to deliver particularly strong additional benefits, which likely reduced the economic advantage of the stepped care intervention. Before widespread adop- tion, future studies are now required to refine stepped care models to maximise the cost-effective- ness of each step, including consideration of the most appropriate staff and setting for each step, and with a greater understanding of what is needed for those young people who fail to benefit from low- intensity interventions.
Treatment: pharmacological interventions Existing evidence suggests that some pharmacolog- ical treatments produce similar effects to
psychological treatment in the short-term. For example, in their Cochrane review of pharmacolog- ical treatments of anxiety disorders in children and young people, Ipser, Stein, Hawkridge and Hoppe (2009) found that 58.1% of participants respond to antidepressant medication (particularly selective serotonin reuptake inhibitors (SSRIs)), compared with placebo medication which resulted in a remis- sion rate of 31.5% (Ipser et al., 2009). Similarly, Wang et al. (2017) concluded that SSRIs, serotonin- norepinephrine reuptake inhibitors, and CBT were all effective in reducing anxiety symptoms, while tricyclics and benzodiazepines had limited effect on anxiety symptoms. However, pharmacological inter- ventions are not generally recommended as a first- line treatment due to patient preference (Brown, Deacon, Abramowitz, Dammanna, & Whiteside, 2007), higher attrition than found for psychological therapies and potential adverse events. For exam- ple, increased rates of mild-to-moderate side effects have been reported in SSRI vs placebo conditions for children/adolescents such as fatigue, tremor, insomnia, drowsiness and nausea (Wang et al., 2017). Nevertheless, SSRIs (especially Sertraline) appear to be well-tolerated in as much as severe side effects are relatively rare in paediatric samples (Ipser et al., 2009; March et al., 2004; Walkup et al., 2008). Yet, there are still relatively few studies that have examined the long-term effects of medication on anxiety symptoms or on the developing brain. There are also limited investigations of the outcomes after medication has ceased and few studies have examined the impact and acceptability in the con- text of particular comorbidities or with particular populations (e.g. children with ASD).
Treatment: combined interventions In one of the largest trials with the longest follow-up period of pharmacological and psychological treat- ments, Walkup et al. (2008) evaluated the efficacy of combining psychological and pharmacological treat- ment to improve outcomes for children with anxiety disorders. The authors concluded that combining CBT + SSRI (Sertraline) treatments produced more than 20%–25% greater improvement than CBT alone, SSRI alone or placebo alone. At the 24-week and 36-week follow-up periods, combined treatment continued to show enhanced outcomes (Piacentini et al., 2014); however, in a follow-up 4–12 years later all three treatment conditions were compara- ble. Notably, in this study, families allocated to combined therapy received a greater dose of therapy (including visits with both a psychologist and a psychiatrist) and were aware they were receiving the ‘best’ dose. Future evaluations of combined treat- ments should also include CBT + pill placebo con- ditions to control for these potential expectation effects.
© 2020 Association for Child and Adolescent Mental Health
636 Cathy Creswell et al. J Child Psychol Psychiatr 2020; 61(6): 628–43
Summary and recommendations Anxiety disorders are extremely prevalent in child- hood and adolescence, appear to be on the rise and can cause lifelong impairment – yet very few chil- dren access evidence-based treatments. Developing further understanding of the cognitive, behavioural and environmental factors that contribute to the maintenance of anxiety disorders and to treatment outcomes in both psychological and pharmacologi- cal therapies, and how these operate across devel- opment and among particular populations, will be critical to enable us to continue to improve out- comes for children and young people. However, in parallel we must urgently address the desperate lack of access to evidence-based treatments that families encounter, through the provision of effec- tive, efficient treatments that can be implemented in ways that preserve their effectiveness in routine clinical practice. Developments in technology pro- vide great potential to deliver interventions at scale in ways that preserve integrity, for example, using virtual reality and online interventions – though it will be critical that these are developed and imple- mented in ways that maximise not only outcomes but engagement of children, young people and carers (e.g. Hill et al., 2018) to ensure that the potential widespread benefits are realised. While this review has focused on treatment, the issues raised also highlight the importance of preventing the emergence of anxiety problems among children and young people who are at risk of their develop- ment. This has the potential to bring advantages from intervening before patterns of responding (among the child and those around them) become ingrained and more difficult to reverse (Donovan & Spence, 2000), and by reducing the burden on families and services by minimising the distress and costs associated with childhood anxiety disorders. Few studies have to date evaluated the effect of preventative programmes on the emergence of
anxiety disorders among ‘at-risk’ populations (Lawr- ence, Rooke, & Creswell, 2017), however those that have certainly look promising (e.g. Ginsburg et al., 2018). In addition to advances in treatment research, future research is sorely needed to estab- lish when, with whom and how to best target prevention to optimise accessibility, engagement and effectiveness (Lawrence et al., 2017).
Acknowledgements C.C. is supported by an NIHR Research Professorship (NIHR-RP-2014-04-018). The views and opinions expressed by authors in this publication are those of the authors and do not necessarily reflect those of the NHS, the NIHR, or the Department of Health. C.C. is co- author of the following books and receives royalties from sales: Helping Your Child with Fears and Worries (2nd edition; LittleBrown), Overcoming your child’s fears and worries (Little Brown), Overcoming your child’s social anxiety and shyness (LittleBrown), Par- ent-led CBT for child anxiety: helping parents help their kids (Guilford Press). P.W. is supported by an NIHR Postdoctoral Research Fellowship (PDF-2016-09-092). P.W. is co-editor of the Helping Your Child series (LittleBrown) and co-author of the following books and receives royalties from sales: Can I tell you about anxiety: A guide for friends, family and professionals (Jessica Kingsley) and Obsessive–compulsive disorder (CBT with children, adolescents and families) (Rout- ledge). J.H. is a co-author of the Cool Kids programme and does not directly receive royalties. She is also an author of the following books and receives royalties from sales: Treating anxious children: An evidence- based approach (New Harbinger).
Correspondence Cathy Creswell, Departments of Experimental Psychol- ogy and Psychiatry, University of Oxford, Anna Watts Building, Radcliffe Observatory Quarter, Woodstock Road, Oxford OX2 6HG, UK; Email: cathy.creswell@p- sych.ox.ac.uk
Key points
Key practitioner messages:
� Assessment of anxiety disorders should routinely involve valid and reliable interview and questionnaire measures of anxiety disorders and other common comorbid problems.
� Cognitive behaviour therapy is effective for treating anxiety disorders in children and young people. � There is currently insufficient evidence for the effectiveness of any other psychological treatment. � There is evidence that SSRIs are effective in the short-medium term, but there is a lack of longer-term
evaluation. � Few children who could benefit receive treatment for anxiety disorders. Brief guided interventions that can
be delivered by nonspecialists are effective for some preadolescent children and provide a means to increase access to psychological interventions, potentially within a stepped care model, but less is known about their effectiveness for adolescents.
© 2020 Association for Child and Adolescent Mental Health
doi:10.1111/jcpp.13186 Anxiety disorders in children and young people 637
Areas for future research:
� Experimental studies to elucidate (cognitive, behavioural, environmental) maintenance mechanisms of anxiety disorders and how they vary across childhood and adolescence and in particular contexts.
� Sufficiently large treatment studies to examine predictors, mediators and moderators of treatment to help optimise treatment outcomes and support improvements in personalised care.
� Use of technology to promote engagement, access, integrity, efficiency and effectiveness of treatments. � Comparisons of different treatment approaches that are fully powered to detect meaningful clinical
differences, with appropriate control conditions (e.g. including placebo where appropriate). � Health economic evaluations to enable health services to increase access by offering the most efficient
treatment approaches. � Implementation research to maximise application and integrity of evidence-based treatments in routine
clinical practice.
References Ale, C.M., McCarthy, D.M., Rothschild, L.M., & Whiteside,
S.P.H. (2015). Components of cognitive behavioral therapy related to outcome in childhood anxiety disorders. Clinical Child and Family Psychology Review, 18, 240–251.
American Psychiatric Association (1994). Diagnostic and sta- tistical manual of mental disorders (4th edn). Arlington, VA: Author.
American Psychiatric Association (2013). Diagnostic and sta- tistical manual of mental disorders (5th edn). Arlington, VA: Author.
Angold, A., Costello, E.J., Messer, S.C., Pickles, A., Winder, F., & Silver, D. (1995). Development of a short questionnaire for use in epidemiological studies of depression in children and adolescents. International Journal of Methods in Psychiatric Research, 5, 237–249.
Barkley, R.A. (2012). Barkley functional impairment scale– children and adolescents (BFIS-CA). New York: Guilford Press.
Beidel, D.C. (1996). Assessment of childhood social phobia: Construct, convergent, and discriminative validity of the Social Phobia and Anxiety inventory for Children (SPA-C). Psychological assessment, 8, 235–240.
Beidel, D.C., Turner, S.M., & Morris, T.L. (2000). Behavioral treatment of childhood social phobia. Journal of Consulting and Clinical Psychology, 68, 1072–1080.
Bevan, A., Oldfield, V.B., & Salkovskis, P.M. (2010). A quali- tative study of the acceptability of an intensive format for the delivery of cognitive-behavioural therapy for obsessive- compulsive disorder. British Journal of Clinical Psychology, 49, 173–191.
Birmaher, B., Khetarpal, S., Cully, M., Brent, D.A., & McKen- zie, S. (2003). Screen for Child Anxiety Related Disorders (SCARED)–Parent form and child form (8 years and older). In L. VandeCreek (Ed) Ellis Human Development Institute; et al Innovations in clinical practice: Focus on children & adoles- cents A volume in the innovations in clinical practice series (pp. 99–104). Sarasota, FL: Professional Resource Press/ Professional Resource Exchange Inc.
Blakemore, S.-J. (2018). Inventing ourselves: The secret life of the teenage brain (First US ed.). New York: PublicAffairs.
Bower, P., & Gilbody, S. (2005). Stepped care in psychological therapies: Access, effectiveness and efficiency – Narrative literature review. British Journal of Psychiatry, 186, 11–17.
Broeren, S., Newall, C., Dodd, H.F., Locker, R., & Hudson, J.L. (2014). Longitudinal investigation of the role of temperament and stressful life events in childhood anxiety. Development and Psychopathology, 26, 437–449.
Brown, A.M., Deacon, B.J., Abramowitz, J.S., Dammanna, J., & Whiteside, S.P. (2007). Parents’ perceptions of
pharmacological and cognitive-behavioral treatments for childhood anxiety disorders. Behaviour Research and Ther- apy, 45, 819–828.
Cartwright-Hatton, S., McNally, D., Field, A.P., Rust, S., Laskey, B., Dixon, C., . . . & Woodham, A. (2011). A new parenting-based group intervention for young anxious chil- dren: Results of a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 50, 242–251.
Chalfant, A.M., Rapee, R., & Carroll, L. (2007). Treating anxiety disorders in children with high functioning autism spectrum disorders: A controlled trial. Journal of Autism and Develop- mental Disorders, 37, 1842–1857.
Chatterton, M.L., Rapee, R.M., Catchpool, M., Lyneham, H.J., Wuthrich, V., Hudson, J.L., . . . & Mihalopoulos, C. (2019). Economic evaluation of stepped care for the management of childhood anxiety disorders: Results from a randomised trial. Australian and New Zealand Journal of Psychiatry, 53, 673–682.
Cheesman, R., Rayner, C., & Eley, T. (2019). The genetic basis of child and adolescent anxiety. In S.N. Compton, M.A. Villabo & H. Kristensen (Eds.), Pediatric anxiety disorders (pp. 17–46). Amsterdam: Elsevier.
Chorpita, B.F., Yim, L., Moffitt, C., Umemoto, L.A., & Francis, S.E. (2000). Assessment of symptoms of DSMIV anxiety and depression in children: a revised child anxiety and depres- sion scale. Behaviour Research and Therapy, 38, 835–855.
Choudhury,M.S.,Pimentel,S.S.,&Kendall,P.C.(2003).Parent- child agreement for diagnosis of anxiety disorders based on structured clinical interview. Journal of the American Acad- emy of Child and Adolescent Psychiatry, 42, 957–964.
Clark, D.M. (1986). A cognitive approach to panic. Behaviour Research and Therapy, 24, 461–470.
Clark, D.M., & Wells, A. (1995). A cognitive model of social phobia. In R.G. Heimberg, M. Liebowitz, D. Hope & F. Schneier (Eds.), Social phobia: Diagnosis, assessment and treatment (pp. 69–93). New York: Guilford Press.
Clauss, J.A., & Blackford, J.U. (2012). Behavioral inhibition and risk for developing social anxiety disorder: a meta- analytic study. Journal of the American Academy of Child and Adolescent Psychiatry, 51, 1066–1075.e1061.
Cobham, V.E. (2012). Do anxiety-disordered children need to come into the clinic for efficacious treatment? Journal of Consulting and Clinical Psychology, 80, 465–476.
Comer, J.S., & Kendall, P.C. (2004). A symptom-level exami- nation of parent-child agreement in the diagnosis of anxious youths. Journal of the American Academy of Child & Adolescent Psychiatry, 43, 878–886.
Conaughton, R.J., Donovan, C.L., & March, S. (2017). Efficacy of an internet-based CBT program for children with comor- bid High Functioning Autism Spectrum Disorder and
© 2020 Association for Child and Adolescent Mental Health
638 Cathy Creswell et al. J Child Psychol Psychiatr 2020; 61(6): 628–43
anxiety: A randomised controlled trial. Journal of Affective Disorders, 218, 260–268.
Copeland, W.E., Angold, A., Shanahan, L., & Costello, E.J. (2014). Longitudinal patterns of anxiety from childhood to adulthood: the Great Smoky Mountains Study. Journal of the American Academy of Child and Adolescent Psychiatry, 53, 21–33.
Craddock, N., Antebi, D., Attenburrow, M.J., Bailey, A., Carson, A., Cowen, P., . . . & Zammit, S. (2008). Wake up call for British psychiatry. British Journal of Psychiatry, 193, 6–9.
Craske, M.G., Kircanski, K., Zelikowsky, M., Mystkowski, J., Chowdhury, N., & Baker, A. (2008). Optimizing inhibitory learning during exposure therapy. Behaviour Research and Therapy, 46, 5–27.
Craske, M.G., Treanor, M., Conway, C.C., Zbozinek, T., & Vervliet, B. (2014). Maximizing exposure therapy: An inhibitory learning approach. Behaviour Research and Ther- apy, 58, 10–23.
Creswell, C., Violato, M., Cruddace, S., Gerry, S., Murray, L., Shafran, R., . . . & Cooper, P.J. (2020). A randomised controlled trial of treatments of childhood anxiety disorder in the context of maternal anxiety disorder: clinical and cost- effectiveness outcomes. Journal of Child Psychology and Psychiatry, 1, 62–76.
Creswell, C., Violato, M., Fairbanks, H., White, E., Parkinson, M., Abitabile, G., . . . & Cooper, P.J. (2017). Clinical outcomes and cost-effectiveness of brief guided parent-delivered cogni- tive behavioural therapy and solution-focused brief therapy for treatment of childhood anxiety disorders: a randomised controlled trial. The Lancet Psychiatry, 4, 529–539.
De Rosnay, M., Cooper, P.J., Tsigaras, N., & Murray, L. (2006). Transmission of social anxiety from mother to infant: an experimental study using a social referencing paradigm. Behaviour Research and Therapy, 44, 1165–1175.
de Wilde, A., & Rapee, R.M. (2008). Do controlling maternal behaviours increase state anxiety in children’s responses to a social threat? A pilot study. Journal of Behavior Therapy and Experimental Psychiatry, 39, 526–537.
Donovan, C.L., & March, S. (2014). Online CBT for preschool anxiety disorders: A randomised control trial. Behaviour Research and Therapy, 58, 24–35.
Donovan, C.L., & Spence, S.H. (2000). Prevention of child- hood anxiety disorders. Clinical Psychology Review, 20, 509–531.
Ebert, D.D., Zarski, A.-C., Christensen, H., Stikkelbroek, Y., Cuijpers, P., Berking, M., & Riper, H. (2015). Internet and computer-based cognitive behavioral therapy for anxiety and depression in youth: A meta-analysis of randomized controlled outcome trials. PloS One, 10, e0119895.
Eley, T.C., Napolitano, M., Lau, J.Y.F., & Gregory, A.M. (2010). Does childhood anxiety evoke maternal control? A geneti- cally informed study. Journal of Child Psychology and Psychiatry, 51, 772–779.
Essau, C.A. (2003). Comorbidity of anxiety disorders in ado- lescents. Depression and Anxiety, 18, 1–6.
Evans, R., Thirlwall, K., Cooper, P., & Creswell, C. (2017). Using symptom and interference questionnaires to identify recovery among children with anxiety disorders. Psycholog- ical Assessment, 29, 835–843.
Fialko, L., Bolton, D., & Perrin, S. (2012). Applicability of a cognitive model of worry to children and adolescents. Behaviour Research and Therapy, 50, 341–349.
Field, A.P., & Lawson, J. (2003). Fear information and the development of fears during childhood: effects on implicit fear responses and behavioural avoidance. Behaviour Research and Therapy, 41, 1277–1293.
Fineberg, N.A., Haddad, P.M., Carpenter, L., Gannon, B., Sharpe, R., Young, A.H., . . . & Sahakian, B.J. (2013). The size, burden and cost of disorders of the brain in the UK. Journal of Psychopharmacology, 27, 761–770.
Fleming, T.M., Bavin, L., Stasiak, K., Hermansson-Webb, E., Merry, S.N., Cheek, C., . . . & Hetrick, S. (2017). Serious games and gamification for mental health: Current status and promising directions. Frontiers in Psychiatry, 7, 215.
Fonagy, P., Pugh, K., & O’Herlihy, A. (2017). The Children and Young People’s Improving Access to Psychological Therapies (CYP IAPT) Programme in England. In D. Skuse, H. Bruce & L. Dowdney (Eds.), Child psychology and psychiatry: Frame- works for clinical training and practice (3rd edn). Oxford, UK: JohnWiley&Sons.9781119170181,ISBN:9781119170235, https://doi.org/10.1002/9781119170235
Francis, D.A., Caruana, N., Hudson, J.L., & McArthur, G.M. (2019). The association between poor reading and internal- ising problems: A systematic review and meta-analysis. Clinical Psychology Review, 67, 45–60.
Freeman, D., Haselton, P., Freeman, J., Spanlang, B., Kishore, S., Albery, E., . . . & Nickless, A. (2018). Automated psycho- logical therapy using immersive virtual reality for treatment of fear of heights: A single-blind, parallel-group, randomised controlled trial. The Lancet Psychiatry, 5, 625–632.
Gibby, B.A., Casline, E.P., & Ginsburg, G.S. (2017). Long-term outcomes of youth treated for an anxiety disorder: A critical review. Clinical child and family psychology review, 20, 201– 225.
Ginsburg, G.S., Becker-Haimes, E.M., Keeton, C., Kendall, P.C., Iyengar, S., Sakolsky, D., . . . & Piacentini, J. (2018). Results from the child/adolescent anxiety multimodal extended long-term study (CAMELS): primary anxiety out- comes. Journal of the American Academy of Child & Adoles- cent Psychiatry, 57, 471–480.
Ginsburg, G.S., Kendall, P.C., Sakolsky, D., Compton, S.N., Piacentini, J., Albano, A.M., . . . & Keeton, C.P. (2011). Remission after acute treatment in children and adolescents with anxiety disorders: Findings from the CAMS. Journal of Consulting and Clinical Psychology, 79, 806.
Glod, M., Creswell, C., Waite, P., Jamieson, R., McConachie, H., Don South, M., & Rodgers, J. (2017). Comparisons of the factor structure and measurement invariance of the Spence Children’s Anxiety Scale—parent version in children with autism spectrum disorder and typically developing anxious children. Journal of Autism and Developmental Disorders, 47, 3834–3846.
Green, H., McGinnity, A., Meltzer, H., Ford, T., & Goodman, G. (2005). Mental health of children and young people in Great Britain, 2004. Retrieved from Basingstoke.
Grills, A.E., & Ollendick, T.H. (2003). Multiple informant agreement and the anxiety disorders interview schedule for parents and children. Journal of the American Academy of Child & Adolescent Psychiatry, 42, 30–40.
Gunter, R.W., & Whittal, M.L. (2010). Dissemination of cogni- tive-behavioral treatments for anxiety disorders: Overcom- ing barriers and improving patient access. Clinical Psychology Review, 30, 194–202.
Halldorsson, B., & Creswell, C. (2017). Social anxiety in pre- adolescent children: What do we know about maintenance? Behaviour Research and Therapy, 99, 19–36.
Hancock, K.M., Swain, J., Hainsworth, C.J., Dixon, A.L., Koo, S., & Munro, K. (2018). Acceptance and commitment ther- apy versus cognitive behavior therapy for children with anxiety: Outcomes of a randomized controlled trial. Journal of Clinical Child & Adolescent Psychology, 47, 296–311.
Hill, C., Creswell, C., Vigerland, S., Nauta, M.H., March, S., Donovan, C., . . . & Kendall, P.C. (2018). Navigating the development and dissemination of internet cognitive behav- ioral therapy (iCBT) for anxiety disorders in children and young people: A consensus statement with recommenda- tions from the #iCBTLorentz Workshop Group. Internet Interventions-the Application of Information Technology in Mental and Behavioural Health, 12, 1–10.
Hiller, R.M., Apetroaia, A., Clarke, K., Hughes, Z., Orchard, F., Parkinson, M., & Creswell, C. (2016). The effect of targeting
© 2020 Association for Child and Adolescent Mental Health
doi:10.1111/jcpp.13186 Anxiety disorders in children and young people 639
tolerance of children’s negative emotions among anxious parents of children with anxiety disorders: A pilot ran- domised controlled trial. Journal of Anxiety Disorders, 42, 52–59.
Hodson, K., McManus, F., Clark, D.M., & Doll, H. (2008). Cognitive model of social phobia be applied to young people? Behavioural and Cognitive Psychotherapy, 36, 449–461.
Hudson, J.L., & Dodd, H.F. (2012). Informing early interven- tion: Preschool predictors of anxiety disorders in middle childhood. PLoS ONE, 7, e42359.
Hudson, J.L., Doyle, A.M., & Gar, N. (2009). Child and maternal influence on parenting behaviour in clinically anxious children. Journal of Clinical Child and Adolescent Psychology, 38, 256–262.
Hudson, J.L., Keers, R., Roberts, S., Coleman, J.R., Breen, G., Arendt, K., . . . & Hartman, C. (2015). Clinical predictors of response to cognitive-behavioral therapy in pediatric anxiety disorders: the Genes for Treatment (GxT) study. Journal of the American Academy of Child & Adolescent Psychiatry, 54, 454–463.
Hudson, J.L., Lester, K.J., Lewis, C.M., Tropeano, M., Cres- well, C., Collier, D.A., . . . & Eley, T.C. (2013). Predicting outcomes following cognitive behaviour therapy in child anxiety disorders: the influence of genetic, demographic and clinical information. Journal of Child Psychology and Psy- chiatry, 54, 1086–1094.
Hudson, J.L., Murayama, K., Meteyard, L., Morris, T., & Dodd, H.F. (2019). Early childhood predictors of anxiety in early adolescence. Journal of Abnormal Child Psychology, 47, 1121–1133.
Hudson, J.L., Newall, C., Rapee, R.M., Lyneham, H.J., Sch- niering, C.C., Wuthrich, V.M., . . . & Gar, N.S. (2014). The impact of brief parental anxiety management on child anxiety treatment outcomes: a controlled trial. Journal of Clinical Child & Adolescent Psychology, 43, 370–380.
Hudson, J.L., Newall, C., Schneider, S.C., & Morris, T.L. (2014). Assessing child and adolescent internalizing disor- ders. In E. Sburlati, H.J. Lyneham, C.A. Schniering & R. Rapee (Eds.), Evidence-based CBT for anxiety and depres- sion in children and adolescents: A competencies based approach (pp. 79–94). Hoboken, NJ: Wiley.
Hudson, J.L., Rapee, R.M., Deveney, C., Schniering, C.A., Lyneham, H.J., & Bovopoulos, N. (2009). Cognitive-behav- ioral treatment versus an active control for children and adolescents with anxiety disorders: A randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry, 48, 533–544.
Ingul, J.M., Aune, T., & Nordahl, H.M. (2014). A randomized controlledtrialofindividualcognitivetherapy,groupcognitive behaviour therapy and attentional placebo for adolescent socialphobia.PsychotherapyandPsychosomatics,83,54–61.
Ipser, J.C., Stein, D.J., Hawkridge, S., & Hoppe, L. (2009). Pharmacotherapy for anxiety disorders in children and adolescents (Review). Cochrane Database of Systematic Reviews, 3, CD005170.
Ishikawa, S.I., Kikuta, K., Sakai, M., Mitamura, T., Motomura, N., & Hudson, J.L. (2019). A randomized controlled trial of a bidirectional cultural adaptation of cognitive behavior ther- apy for children and adolescents with anxiety disorders. Behavior Research and Therapy, 120, 103432.
James, A.C., James, G., Cowdrey, F.A., Soler, A., & Choke, A. (2013). Cognitive behavioural therapy for anxiety disorders in children and adolescents (Review). The Cochrane Library, 6, CD004690.
Jitlina, K., Zumbo, B., Mirenda, P., Ford, L., Bennett, T., Georgiades, S., . . . & Elsabbagh, M. (2017). Psychometric properties of the Spence Children’s Anxiety Scale: Parent report in children with autism spectrum disorder. Journal of autism and developmental disorders, 47, 3847–3856.
Kazdin, A.E. (2003). Methodology: General lessons to guide research. In A.E. Kazdin (Ed.), Methodological issues &
strategies in clinical research (3rd ed., pp. 877–887). Wash- ington, DC: American Psychological Association.
Keeton, C.P., Teetsel, R.N., Dull, N.M.S., & Ginsburg, G.S. (2015). Parent psychopathology and children’s psychological health: Moderation by sibling relationship dimensions. Journal of Abnormal Child Psychology, 43, 1333–1342.
Keles, B., McCrae, N., & Grealish, A. (2019). A systematic review: the influence of social media on depression, anxiety and psychological distress in adolescents. International Journal of Adolescence and Youth, 1–15.
Kendall, P.C., Cummings, C.M., Villabo, M.A., Narayanan, M.K., Treadwell, K., Birmaher, B., . . . & Albano, A.M. (2016). Mediators of change in the Child/Adolescent Anxiety Mul- timodal Treatment Study. Journal of Consulting and Clinical Psychology, 84, 1–14.0
Kerns, C.M., & Kendall, P.C. (2012). The presentation and classification of anxiety in autism spectrum disorder. Clin- ical Psychology-Science and Practice, 19, 323–347.
Kim, K.J., Conger, R.D., Elder, G.H., Jr., & Lorenz, F.O. (2003). Reciprocal influences between stressful life events and adolescent internalizing and externalizing problems. Child Development, 74, 127–143.
Langley, A.K., Bergman, R.L., McCracken, J., & Piacentini, J.C. (2004). Impairment in childhood anxiety disorders: preliminary examination of the child anxiety impact scale- parent version. Journal of Child and Adolescent Psychophar- macology, 14, 105–114.
Lawrence, D., Johnson, S., Hafekost, J., Boterhoven de Haan, K., Sawyer, M., Ainley, J., & Zubrick, S.R. (2015). The Mental Health of Children and Adolescents. Report on the second Australian Child and Adolescent Survey of Mental Health and Wellbeing. Department of Health, Canberra.
Lawrence, P.J., Murayama, K., & Creswell, C. (2019). System- atic review and meta-analysis: Anxiety and depressive disorders in offspring of parents with anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 58, 46–60.
Lawrence, P.J., Rooke, S.M., & Creswell, C. (2017). Prevention of anxiety among at-risk children and adolescents–a sys- tematic review and meta-analysis. Child and Adolescent Mental Health, 22, 118–130.
Lawrence, P.J., Waite, P., & Creswell, C. (2019). Environmen- tal factors in the development and maintenance of anxiety disorders. In S.N. Compton, M.A. Villabo & H. Kristensen (Eds.), Pediatric anxiety disorders (pp. 101–124). Amster- dam: Elsevier.
Leigh, E., & Clark, D.M. (2015). Cognitive therapy for social anxiety disorder in adolescents: A development case series. Behavioural and Cognitive Psychotherapy, 44, 1–17.
Leigh, E., & Clark, D.M. (2018). Understanding social anxiety disorder in adolescents and improving treatment outcomes: applying the cognitive model of Clark and Wells (1995). Clinical Child and Family Psychology Review, 21, 388–414.
Lenhard, F., Vigerland, S., Engberg, H., Hallberg, A., Ther- maenius, H., & Serlachius, E. (2016). “On My Own, but Not Alone” – Adolescents’ experiences of internet-delivered cog- nitive behavior therapy for obsessive-compulsive disorder. PLoS ONE, 11, e0164311.
Leyfer, O., Gallo, K.P., Cooper-Vince, C., & Pincus, D.B. (2013). Patterns and predictors of comorbidity of DSM-IV anxiety disorders in a clinical sample of children and adolescents. Journal of Anxiety Disorders, 27, 306–311.
Lyneham, H.J., Sburlati, E.S., Abbott, M.J., Rapee, R.M., Hudson, J.L., Tolin, D.F., & Carlson, S.E. (2013). Psycho- metric properties of the Child Anxiety Life Interference Scale (CALIS). Journal of Anxiety Disorders, 27, 711–719.
Lyneham, H.J., Street, A.K., Abbott, M.J., & Rapee, R.M. (2008). Psychometric properties of the school anxiety scale— Teacher report (SAS-TR). Journal of Anxiety Disorders, 22, 292–300.
© 2020 Association for Child and Adolescent Mental Health
640 Cathy Creswell et al. J Child Psychol Psychiatr 2020; 61(6): 628–43
Magiati, I., Lerh, J.W., Hollocks, M.J., Uljarevic, M., Rodgers, J., McConachie, H., . . . & Hardan, A. (2017). The measure- ment properties of the spence children’s anxiety scale- parent version in a large international pooled sample of young people with autism spectrum disorder. Autism Research, 10, 1629–1652.
Maiano, C., Coutu, S., Tracey, D., Bouchard, S., Lepage, G., Morin, A.J.S., & Moullec, G. (2018). Prevalence of anxiety and depressive disorders among youth with intellectual disabilities: A systematic review and meta-analysis. Journal of Affective Disorders, 236, 230–242.
Manassis, K., Mendlowitz, S.L., Scapillato, D., Avery, D., Fik- senbaum, L., Freire, M., . . . & Owens, M. (2002). Group and individual cognitive-behavioral therapy for childhood anxiety disorders: A Randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 1423–1430.
March, J.S., Foa, E., Gammon, P., Chrisman, A., Curry, J., Fitzgerald, D., . . . & Pediatric OCD Treatment Study (POTS) Team (2004). Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obses- sive-compulsive disorder – The Pediatric OCD Treatment Study (POTS) randomized controlled trial. Journal of the American Medical Association, 292, 1969–1976.
March, J.S., Parker, J.D., Sullivan, K., Stallings, P., & Conners, C.K. (1997). The Multidimensional Anxiety Scale for Children (MASC): Factor structure, reliability, and valid- ity. Journal of the American Academy of Child & Adolescent Psychiatry, 36, 554–565.
Martin, A.M., Fishman, R., Baxter, L., & Ford, T. (2011). Practitioners’ attitudes towards the use of standardized diagnostic assessment in routine practice: a qualitative study in two child and adolescent mental health services. Clinical Child Psychology and Psychiatry, 16, 407–420.
Masia Warner, C., Fisher, P.H., Shrout, P.E., Rathor, S., & Klein, R.G. (2007). Treating adolescents with social anxiety disorder in school: An attention control trial. Journal of Child Psychology and Psychiatry, 48, 676–686.
Masia-Warner, C., Klein, R.G., Dent, H.C., Fisher, P.H., Alvir, J., Albano, A.M., & Guardino, M. (2005). School-based intervention for adolescents with social anxiety disorder: Results of a controlled study. Journal of Abnormal Child Psychology, 33, 707–722.
Maskey, M., Lowry, J., Rodgers, J., McConachie, H., & Parr, J.R. (2014). Reducing specific phobia/fear in young people with autism spectrum disorders (ASDs) through a virtual reality environment intervention. PLoS ONE, 9, e100374.
Merikangas, K.R., He, J.P., Burstein, M., Swendsen, J., Avenevoli, S., Case, B., . . . & Olfson, M. (2011). Service utilization for lifetime mental disorders in U.S. adolescents: results of the National Comorbidity Survey-Adolescent Sup- plement (NCS-A). Journal of the American Academy of Child and Adolescent Psychiatry, 50, 32–45.
Monga, S., Rosenbloom, B.N., Tanha, A., Owens, M., & Young, A. (2015). Comparison of child–parent and parent-only cognitive-behavioral therapy programs for anxious children aged 5 to 7 years: Short-and longterm outcomes. Journal of the American Academy of Child & Adolescent Psychiatry, 54, 138–146.
Muris, P., & Ollendick, T.H. (2015). Children who are anxious in silence: A review on selective mutism, the new anxiety disorder in DSM-5. Clinical Child and Family Psychology Review, 18, 151–169.
Muris, P., Simon, E., Lijphart, H., Bos, A., Hale, W., & Schmeitz, K. (2017). The youth anxiety measure for DSM-5 (YAM-5): Development and first psychometric evidence of a new scale for assessing anxiety disorders symptoms of children and adolescents. Child Psychiatry & Human Devel- opment, 48, 1–17.
Nauta, M.H., Scholing, A., Rapee, R.M., Abbott, M., Spence, S.H., & Waters, A.M. (2004). A parent-report measure of children’s anxiety: Psychometric properties and comparison
with child-report in a clinic and normal sample. Behavior Research & Therapy, 42, 813–839.
NICE (2013). Social anxiety disorder: Recognition, assessment and treatment (CG159). Available from: https://www.nice. org.uk/guidance/cg159 [last accessed 13 May 2019].
Oerbeck, B., Stein, M.B., Wentzel-Larsen, T., Langsrud, Ø., & Kristensen, H. (2014). A randomized controlled trial of a home and school-based intervention for selective mutism– defocused communication and behavioural techniques. Child and Adolescent Mental Health, 19, 192–198.
Ollendick, T.H., Lewis, K.M., Cowart, M.J.W., & Davis, T. (2012). Prediction of child performance on a parent-child behavioral approach test with animal phobic children. Behavior Modification, 36, 509–524.
Ollendick, T.H., Ost, L.G., Reuterskiold, L., Costa, N., Ceder- lund, R., Sirbu, C., . . . & Jarrett, M.A. (2009). One-session treatment of specific phobias in youth: a randomized clinical trial in the United States and Sweden. Journal of Consulting and Clinical Psychology, 77, 504–516.
O’Neil Rodriguez, K.A., & Kendall, P.C. (2014). Suicidal ideation in anxiety-disordered youth: Identifying predictors of risk. Journal of Clinical Child and Adolescent Psychology, 43, 51–62.
€Ost, L.-G., Cederlund, R., & Reuterski€old, L. (2015). Behav- ioral treatment of social phobia in youth: Does parent education training improve the outcome? Behaviour Research and Therapy, 67, 19–29.
Pao, M., & Bosk, A. (2011). Anxiety in medically ill children/ adolescents. Depress Anxiety, 28, 40–49.
Parrish, D.E., Oxhandler, H.K., Duron, J.F., Swank, P., & Bordnick, P. (2016). Feasibility of virtual reality environ- ments for adolescent social anxiety disorder. Research on Social Work Practice, 26, 825–835.
Pennant, M.E., Loucas, C.E., Whittington, C., Creswell, C., Fonagy, P., Fuggle, P., . . . & Grp, E.A. (2015). Computerised therapies for anxiety and depression in children and young people: A systematic review and meta-analysis. Behaviour Research and Therapy, 67, 1–18.
Peris, T.S., Compton, S.N., Kendall, P.C., Birmaher, B., Sherrill, J., March, J., . . . & Piacentini, J. (2015). Trajec- tories of change in youth anxiety during cognitive-behavior therapy. Journal of Consulting and Clinical Psychology, 83, 239–252.
Piacentini, J., Bennett, S., Compton, S.N., Kendall, P.C., Birmaher, B., Albano, A.M., . . . & Walkup, J. (2014). 24- and 36-Week Outcomes for the Child/Adolescent Anxiety Multimodal Study (CAMS). Journal of the American Academy of Child and Adolescent Psychiatry, 53, 297–310.
Pina, A.A., Silverman, W.K., Fuentes, R.M., Kurtines, W.M., & Weems, C.F. (2003). Exposure-based cognitive-behavioral treatment for phobic and anxiety disorders: Treatment effects and maintenance for Hispanic/Latino relative to European-American youths. Journal of the American Acad- emy of Child & Adolescent Psychiatry, 42, 1179–1187.
Polanczyk, G.V., Salum, G.A., Sugaya, L.S., Caye, A., & Rohde, L.A. (2015). Annual research review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. Journal of Child Psychology and Psychiatry, 56, 345–365.
Price, C.S., Spence, S.H., Sheffield, J., & Donovan, C. (2002). The development and psychometric properties of a measure of social and adaptive functioning for children and adoles- cents. Journal of Clinical Child and Adolescent Psychology, 31, 111–122.
Rapee, R.M., Abbott, M.J., & Lyneham, H.J. (2006). Biblio- therapy for children with anxiety disorders using written materials for parents: A randomized controlled trial. Journal of Consulting and Clinical Psychology, 74, 436–444.
Rapee, R.M., & Heimberg, R.G. (1997). A cognitive-behavioral model of anxiety in social phobia. Behaviour Research and Therapy, 35, 741–756.
© 2020 Association for Child and Adolescent Mental Health
doi:10.1111/jcpp.13186 Anxiety disorders in children and young people 641
Rapee, R.M., Lyneham, H.J., Wuthrich, V., Chatterton, M.L., Hudson, J.L., Kangas, M., & Mihalopoulos, C. (2017). Comparison of stepped care delivery against a single, empirically validated cognitive-behavioral therapy program for youth with anxiety: A Randomized Clinical Trial. Journal of the American Academy of Child and Adolescent Psychia- try, 56, 841–848.
Reardon, T., Creswell, C., Lester, K.J., Arendt, K., Blatter- Meunier, J., B€ogels, S.M., . . . & Herren, C. (2019). The utility of the SCAS-C/P to detect specific anxiety disorders among clinically anxious children. Psychological Assessment, 31, 1006–1018.
Reardon, T., Harvey, K., & Creswell, C. (2019). Seeking and accessing professional support for child anxiety in a com- munity sample. European Child and Adolescent Psychiatry. https://doi.org/10.1007/s00787-019-01388-4
Reardon, T., Spence, S.H., Hesse, J., Shakir, A., & Creswell, C. (2018). Identifying children with anxiety disorders using brief versions of the Spence Children’s Anxiety Scale for children, parents, and teachers. Psychological assessment, 30, 1342.
Reed, G.M., First, M.B., Kogan, C.S., Hyman, S.E., Gureje, O., Gaebel, W., . . . & Tyrer, P. (2019). Innovations and changes in the ICD-11 classification of mental, behavioural and neurodevelopmental disorders. World Psychiatry, 18, 3–19.
Reijntjes, A., Kamphuis, J.H., Prinzie, P., & Telch, M.J. (2010). Peer victimization and internalizing problems in children: A meta-analysis of longitudinal studies. Child Abuse & Neglect, 34, 244–252.
Reynolds, S., Wilson, C., Austin, J., & Hooper, L. (2012). Effects of psychotherapy for anxiety in children and adoles- cents: A meta-analytic review. Clinical Psychology Review, 32, 251–262.
Robinson, J., Sareen, J., Cox, B.J., & Bolton, J.M. (2011). Role of self-medication in the development of comorbid anxiety and substance use disorders: A longitudinal investigation. Archives of General Psychiatry, 68, 800–807.
Rubin, K.H., Burgess, K.B., & Hastings, P.D. (2002). Stability and social-behavioral consequences of toddlers’ inhibited temperament and parenting behaviors. Child Development, 73, 483–495.
Schneider, S., Blatter-Meunier, J., Herren, C., Adornetto, C., In-Albon, T., & Lavallee, K. (2011). Disorderspecific cogni- tive-behavioral therapy for separation anxiety disorder in young children: A randomized waiting-list-controlled trial. Psychotherapy and Psychosomatics, 80, 206.
Silk, J.S., Tan, P.Z., Ladouceur, C.D., Meller, S., Siegle, G.J., McMakin, D.L., . . . & Mannarino, A. (2018). A randomized clinical trial comparing individual cognitive behavioral ther- apy and child-centered therapy for child anxiety disorders. Journal of Clinical Child & Adolescent Psychology, 47, 542– 554.
Silverman, W.K., & Albano, A.M. (1996). The anxiety disorders interview schedule for DSM-IV – Child and parent versions. San Antonio, TX: Psychological Corporation.
Silverman, W.K., Marin, C.E., Rey, Y., Kurtines, W.M., Jac- card, J., & Pettit, J.W. (2019). Group- versus parent- involvement CBT for childhood anxiety disorders: Treatment specificity and long-term recovery mediation. Clinical Psy- chological Science, 7, 840–855.
Silverman, W.K., & Ollendick, T.H. (2005). Evidence-based assessment of anxiety and its disorders in children and adolescents. Journal of Clinical Child and Adolescent Psy- chology, 34, 380–411.
Spence, S.H. (2017). Review-Measurement Issues: Assessing anxiety disorders in children and adolescents. Child and Adolescent Mental Health, 23, 266–282.
Spence, S.H., Barrett, P.M., & Turner, C.M. (2003). Psycho- metric properties of the Spence Children’s Anxiety Scale with young adolescents. Journal of anxiety disorders, 17, 605– 625.
Spence, S.H., Donovan, C.L., & Brechman-Toussaint, M. (2000). The treatment of childhood social phobia: The effectiveness of a social skills training-based, cognitive- behavioural intervention, with and without parental involve- ment. Journal of Child Psychology and Psychiatry, 41, 713– 726.
Spence, S.H., Donovan, C.L., March, S., Gamble, A., Anderson, R.E., Prosser, S., & Kenardy, J. (2011). A Randomized Controlled Trial of Online Versus Clinic-Based CBT for adolescent anxiety. Journal of Consulting and Clinical Psy- chology, 79, 629–642.
Spence, S.H., & Rapee, R.M. (2016). The etiology of social anxiety disorder: An evidence-based model. Behaviour Research and Therapy, 86, 50–67.
Spence, S.H., Zubrick, S.R., & Lawrence, D. (2018). A profile of social, separation and generalized anxiety disorders in an Australian nationally representative sample of children and adolescents: Prevalence, comorbidity and correlates. Aus- tralian and New Zealand Journal of Psychiatry, 52, 446–460.
Stallard, P., Udwin, O., Goddard, M., & Hibbert, S. (2007). The availability of cognitive behaviour therapy within specialist child and adolescent mental health services (CAMHS): A national survey. Behavioural and Cognitive Psychotherapy, 35, 501–505.
Taboas, W.R., McKay, D., Whiteside, S.P.H., & Storch, E.A. (2015). Parental involvement in youth anxiety treatment: Conceptual bases, controversies, and recommendations for intervention. Journal of Anxiety Disorders, 30, 16–18.
Thirlwall, K., Cooper, P.J., Karalus, J., Voysey, M., Willetts, L., & Creswell, C. (2013). Treatment of child anxiety disorders via guided parent-delivered cognitive behavioural therapy: randomised controlled trial. British Journal of Psychiatry, 203, 436–444.
Thirlwall, K., & Creswell, C. (2010). The impact of maternal control on children’s anxious cognitions, behaviours and affect: An experimental study. Behaviour Research and Therapy, 48, 1041–1046.
Thulin, U., Svirsky, L., Serlachius, E., Andersson, G., & Ost, L.G. (2014). The effect of parent involvement in the treat- ment of anxiety disorders in children: A meta-analysis. Cognitive Behaviour Therapy, 43, 185–200.
Toscano, R., Baillie, A.J., Lyneham, H.J., Kelly, A., Kidd, T., & Hudson, J.L. (2020). Assessment of anxiety in children and adolescents: A comparative study on the validity and relia- bility of the Spence Children’s Anxiety Scale in children and adolescents with anxiety and Autism Spectrum Disorder. Journal of Affective Disorders, 260, 569–576.
Turner, S.M., Beidel, D.C., & Wolff, P.L. (1996). Is behavioral inhibition related to the anxiety disorders? Clinical Psychol- ogy Review, 16, 157–172.
Vizard, T., Pearce, N., & Davis, J. (2018). Mental health of children and young people in England, 2017. Leeds, UK: Health and Social Care Information Centre.
Voort, J.L.V., Svecova, J., Jacobson, A.B., & Whiteside, S.P.H. (2010). A retrospective examination of the similarity between clinical practice and manualized treatment for childhood anxiety disorders. Cognitive and Behavioral Practice, 17, 322–328.
Waite, P., & Creswell, C. (2014). Children and adolescents referred for treatment of anxiety disorders: Differences in clinical characteristics. Journal of Affective Disorders, 167, 326–332.
Waite, P., & Creswell, C. (2015). Observing interactions between children and adolescents and their parents: The effects of anxiety disorder and age. Journal of Abnormal Child Psychology, 43, 1079–1091.
Waite, P., Marshall, T., & Creswell, C. (2019). A randomized controlled trial of internet-delivered cognitive behaviour therapy for adolescent anxiety disorders in a routine clinical care setting with and without parent sessions. Child and Adolescent Mental Health, 24, 242–250.
© 2020 Association for Child and Adolescent Mental Health
642 Cathy Creswell et al. J Child Psychol Psychiatr 2020; 61(6): 628–43
Walkup, J.T., Albano, A.M., Piacentini, J., Birmaher, B., Compton, S.N., Sherrill, J.T., . . . & Kendall, P.C. (2008). Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. New England Journal of Medicine, 359, 2753–2766.
Wang, Z., Whiteside, S.P.H., Sim, L., Farah, W., Morrow, A.S., Alsawas, M., . . . & Murad, M.H. (2017). Comparative effective- ness and safety of cognitive behavioral therapy and pharma- cotherapy for childhood anxiety disorders a systematic review and meta-analysis. JAMA Pediatrics, 171, 1049–1056.
Warwick, H., Reardon, T., Cooper, P., Murayama, K., Reynolds, S., Wilson, C., & Creswell, C. (2017). Complete recovery from anxiety disorders following Cognitive Behavior Therapy in children and adolescents: A meta-analysis. Clinical Psychol- ogy Review, 52, 77–91.
Waters, A.M., & Craske, M.G. (2016). Towards a cognitive- learning formulation of youth anxiety: A narrative review of theory and evidence and implications for treatment. Clinical Psychology Review, 50, 50–66.
Waters, A.M., Ford, L.A., Wharton, T.A., & Cobham, V.E. (2009). Cognitive-behavioural therapy for young children with anxiety disorders: Comparison of a child + parent condition versus a parent only condition. Behaviour Research and Therapy, 47, 654–662.
Weisz, J.R., Chorpita, B.F., Palinkas, L.A., Schoenwald, S.K., Miranda, J., Bearman, S.K., . . . & Research Network on Youth Mental Health (2012). Testing standard and modular designs for psychotherapy treating depression, anxiety, and conduct problems in youth: a randomized effectiveness trial. Archives of General Psychiatry, 69, 274–282.
White, J.A., & Hudson, J.L. (2016). The metacognitive model of anxiety in children: towards a reliable and valid measure. Cognitive Therapy and Research, 40, 92–106.
Whiteside, S.P., Ale, C.M., Young, B., Dammann, J.E., Tiede, M.S., & Biggs, B.K. (2015). The feasibility of improving CBT for childhood anxiety disorders through a dismantling study. Behaviour Research and Therapy, 73, 83–89.
Whiteside, S.P.H., Deacon, B.J., Benito, K., & Stewart, E. (2016). Factors associated with practitioners’ use of expo- sure therapy for childhood anxiety disorders. Journal of Anxiety Disorders, 40, 29–36.
Yuan, S., Zhou, X., Zhang, Y., Zhang, H., Pu, J., Yang, L., . . . & Xie, P. (2018). Comparative efficacy and acceptability of bibliotherapy for depression and anxiety disorders in children and adolescents: A meta-analysis of randomized clinical trials. Neuropsychiatric Disease and Treatment, 14, 353.
Zhang, H., Zhang, Y., Yang, L., Yuan, S., Zhou, X., Pu, J., . . . & Xie, P. (2017). Efficacy and acceptability of psychotherapy for anxious young children: A meta-analysis of randomized controlled trials. The Journal of nervous and mental disease, 205, 931–941.
Zhou, X., Zhang, Y., Furukawa, T.A., Cuijpers, P., Pu, J., Weisz, J.R., . . . & Cohen, D. (2019). Different types and acceptability of psychotherapies for acute anxiety disorders in children and adolescents: A network meta-analysis. JAMA Psychiatry, 76, 41–50.
Accepted for publication: 2 December 2019 First published online: 21 January 2020
© 2020 Association for Child and Adolescent Mental Health
doi:10.1111/jcpp.13186 Anxiety disorders in children and young people 643
Copyright of Journal of Child Psychology & Psychiatry is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use.